HealthQuill US Tariffs
Amgen Inc. will expand its Ohio biomanufacturing facility for $900 million, after a recent move to investĀ $1 billionĀ to build a second manufacturing plantĀ inĀ Holly Springs, North Carolina, US.
Drugs Medical Pharma

Amgen to invest $900 million in Ohio biomanufacturing facility

HQ Team April 26, 2025: Amgen Inc. will expand its Ohio biomanufacturing facility for $900 million, after a recent move to investĀ $1 billionĀ to.

Read More